Recombinant gamma interferon stimulates signal transduction and gene expression in alveolar macrophages in vitro and in tuberculosis patients.

PubWeight™: 1.07‹?› | Rank: Top 10%

🔗 View Article (PMC 152019)

Published in Infect Immun on April 01, 2003

Authors

Rany Condos1, Bindu Raju, Antony Canova, Ben-Yang Zhao, Michael Weiden, William N Rom, Richard Pine

Author Affiliations

1: Bellevue Chest Service and Division of Pulmonary and Critical Care Medicine, Department of Medicine, NYU School of Medicine, New York, NY 10016, USA.

Articles citing this

The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research. Proc Am Thorac Soc (2007) 1.65

In vitro differentiation of human macrophages with enhanced antimycobacterial activity. J Clin Invest (2011) 1.29

Exogenous gamma and alpha/beta interferon rescues human macrophages from cell death induced by Bacillus anthracis. Infect Immun (2004) 1.07

IL-10 down-regulates costimulatory molecules on Mycobacterium tuberculosis-pulsed macrophages and impairs the lytic activity of CD4 and CD8 CTL in tuberculosis patients. Clin Exp Immunol (2004) 1.07

Interleukin-10 induces inhibitory C/EBPbeta through STAT-3 and represses HIV-1 transcription in macrophages. Am J Respir Cell Mol Biol (2005) 1.06

Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection. Am J Respir Crit Care Med (2010) 1.03

Specific engagement of TLR4 or TLR3 does not lead to IFN-beta-mediated innate signal amplification and STAT1 phosphorylation in resident murine alveolar macrophages. J Immunol (2004) 1.02

Gene expression profiles of bronchoalveolar cells in pulmonary TB. Tuberculosis (Edinb) (2007) 0.98

Host-directed therapeutics for tuberculosis: can we harness the host? Microbiol Mol Biol Rev (2013) 0.97

Immunomodulation with recombinant interferon-gamma1b in pulmonary tuberculosis. PLoS One (2009) 0.95

Aerosolized gamma interferon (IFN-gamma) induces expression of the genes encoding the IFN-gamma-inducible 10-kilodalton protein but not inducible nitric oxide synthase in the lung during tuberculosis. Infect Immun (2004) 0.93

Surfactant protein A modulates the inflammatory response in macrophages during tuberculosis. Infect Immun (2004) 0.90

Inhaled therapeutics for prevention and treatment of pneumonia. Expert Opin Drug Saf (2009) 0.89

Elevated IP-10 and IL-6 from bronchoalveolar lavage cells are biomarkers of non-cavitary tuberculosis. Int J Tuberc Lung Dis (2013) 0.84

Function and Potentials of M. tuberculosis Epitopes. Front Immunol (2014) 0.84

Extracellular traps and macrophages: new roles for the versatile phagocyte. J Leukoc Biol (2015) 0.81

Wedelolactone, a naturally occurring coumestan, enhances interferon-γ signaling through inhibiting STAT1 protein dephosphorylation. J Biol Chem (2013) 0.79

Impaired activation of Stat1 and c-Jun as a possible defect in macrophages of patients with active tuberculosis. Clin Exp Immunol (2009) 0.79

New drugs and regimens for treatment of TB. Expert Rev Anti Infect Ther (2010) 0.77

Vaccination with an Attenuated Ferritin Mutant Protects Mice against Virulent Mycobacterium tuberculosis. J Immunol Res (2015) 0.77

Adenosine deaminase acting on RNA-1 (ADAR1) inhibits HIV-1 replication in human alveolar macrophages. PLoS One (2014) 0.76

Articles cited by this

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA (1999) 27.82

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med (1993) 18.56

Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med (1993) 17.01

STATs and gene regulation. Science (1997) 16.55

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med (1989) 10.98

Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci U S A (1997) 7.90

A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med (1996) 7.66

Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev (1990) 6.33

STATs: signal transducers and activators of transcription. Cell (1996) 6.10

Proteins of transcription factor ISGF-3: one gene encodes the 91-and 84-kDa ISGF-3 proteins that are activated by interferon alpha. Proc Natl Acad Sci U S A (1992) 5.50

Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med (1996) 5.36

Cytoplasmic activation of ISGF3, the positive regulator of interferon-alpha-stimulated transcription, reconstituted in vitro. Genes Dev (1989) 5.09

Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science (1994) 4.50

Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins. Mol Cell Biol (1992) 3.90

Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide. J Exp Med (1993) 3.48

SOCS proteins: negative regulators of cytokine signaling. Stem Cells (2001) 3.40

Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both beta interferon- and interferon-stimulated genes but is not a primary transcriptional activator of either. Mol Cell Biol (1990) 3.31

Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med (1995) 3.29

Modeling the impact of global tuberculosis control strategies. Proc Natl Acad Sci U S A (1998) 3.22

Tuberculosis in the 1990s. Ann Intern Med (1993) 3.08

Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol (2002) 3.00

Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J Immunol (2001) 2.83

Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J Clin Invest (1998) 2.67

Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science (2001) 2.52

Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFN alpha and IFN gamma, and is likely to autoregulate the p91 gene. EMBO J (1994) 2.50

Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol. Lancet (1997) 2.40

Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. J Immunol (1999) 2.37

Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science (1994) 2.28

Compartmentalization of a CD4+ T lymphocyte subpopulation in tuberculous pleuritis. J Immunol (1989) 2.27

Expression of the nitric oxide synthase 2 gene is not essential for early control of Mycobacterium tuberculosis in the murine lung. Infect Immun (2000) 1.92

Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma- induced genes by suppressing tyrosine phosphorylation of STAT1. Blood (1999) 1.88

Essential and non-redundant roles of p48 (ISGF3 gamma) and IRF-1 in both type I and type II interferon responses, as revealed by gene targeting studies. Genes Cells (1996) 1.86

Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung. Am J Respir Crit Care Med (1997) 1.83

Constitutive expression of an ISGF2/IRF1 transgene leads to interferon-independent activation of interferon-inducible genes and resistance to virus infection. J Virol (1992) 1.77

Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. J Clin Invest (1995) 1.71

Differential binding of interferon-induced factors to an oligonucleotide that mediates transcriptional activation. Nucleic Acids Res (1989) 1.62

ERK1 and ERK2 activate CCAAAT/enhancer-binding protein-beta-dependent gene transcription in response to interferon-gamma. J Biol Chem (2001) 1.44

Local immune responses correlate with presentation and outcome in tuberculosis. Am J Respir Crit Care Med (1998) 1.44

Differentiation of monocytes to macrophages switches the Mycobacterium tuberculosis effect on HIV-1 replication from stimulation to inhibition: modulation of interferon response and CCAAT/enhancer binding protein beta expression. J Immunol (2000) 1.43

Characterization of the inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease. Am Rev Respir Dis (1981) 1.42

Type I interferon induces inhibitory 16-kD CCAAT/ enhancer binding protein (C/EBP)beta, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication. J Exp Med (1998) 1.41

Tuberculosis in HIV-positive patients: cellular response and immune activation in the lung. Am J Respir Crit Care Med (1996) 1.29

Effects of aerosolized interferon-alpha in patients with pulmonary tuberculosis. Am J Respir Crit Care Med (1998) 1.22

CCAAT/enhancer-binding protein-beta regulates interferon-induced transcription through a novel element. J Biol Chem (2000) 1.15

Interferon gamma-induced transcription of the murine ISGF3gamma (p48) gene is mediated by novel factors. Proc Natl Acad Sci U S A (1997) 1.08

Activation of latent HIV-1 by Mycobacterium tuberculosis and its purified protein derivative in alveolar macrophages from HIV-infected individuals in vitro. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.06

Organ specific cytokine therapy. Local activation of mononuclear phagocytes by delivery of an aerosol of recombinant interferon-gamma to the human lung. J Clin Invest (1991) 1.06

Human host response to Mycobacterium tuberculosis. Schweiz Med Wochenschr (1995) 0.88

Host defense responses to infection by Mycobacterium tuberculosis. Induction of IRF-1 and a serine protease inhibitor. J Biol Chem (2002) 0.85

The janus kinase inhibitor, Jab/SOCS-1, is an interferon-gamma inducible gene and determines the sensitivity to interferons. Leuk Lymphoma (2000) 0.80

Articles by these authors

Cough and bronchial responsiveness in firefighters at the World Trade Center site. N Engl J Med (2002) 4.99

Persistent hyperreactivity and reactive airway dysfunction in firefighters at the World Trade Center. Am J Respir Crit Care Med (2003) 3.38

Detection of lung cancer with volatile markers in the breath. Chest (2003) 3.09

Pulmonary function after exposure to the World Trade Center collapse in the New York City Fire Department. Am J Respir Crit Care Med (2006) 2.63

Case series report of a linezolid-containing regimen for extensively drug-resistant tuberculosis. Chest (2008) 2.29

Acute eosinophilic pneumonia in a New York City firefighter exposed to World Trade Center dust. Am J Respir Crit Care Med (2002) 2.26

Survival after surgery in stage IA and IB non-small cell lung cancer. Am J Respir Crit Care Med (2007) 2.24

Basic pathogenetic mechanisms in silicosis: current understanding. Curr Opin Pulm Med (2005) 2.11

Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation. Microbiome (2013) 1.98

Optical detection of buccal epithelial nanoarchitectural alterations in patients harboring lung cancer: implications for screening. Cancer Res (2010) 1.94

Metabolic syndrome biomarkers predict lung function impairment: a nested case-control study. Am J Respir Crit Care Med (2011) 1.86

Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease. Cancer Res (2009) 1.86

Inflammatory biomarkers predict airflow obstruction after exposure to World Trade Center dust. Chest (2012) 1.78

Selective p38 activation in human non-small cell lung cancer. Am J Respir Cell Mol Biol (2002) 1.75

Significance of abnormal chest radiograph findings in patients with HIV-1 infection without respiratory symptoms. Chest (2002) 1.72

Induced sputum assessment in New York City firefighters exposed to World Trade Center dust. Environ Health Perspect (2004) 1.70

A blood-based proteomic classifier for the molecular characterization of pulmonary nodules. Sci Transl Med (2013) 1.69

Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer. PLoS One (2010) 1.66

Prediction of lung cancer using volatile biomarkers in breath. Cancer Biomark (2007) 1.60

Maximal HIV-1 replication in alveolar macrophages during tuberculosis requires both lymphocyte contact and cytokines. J Exp Med (2002) 1.43

Obstructive airways disease with air trapping among firefighters exposed to World Trade Center dust. Chest (2009) 1.43

Bronchial hyperreactivity and other inhalation lung injuries in rescue/recovery workers after the World Trade Center collapse. Crit Care Med (2005) 1.41

CD40 and CD80/86 act synergistically to regulate inflammation and mortality in polymicrobial sepsis. Am J Respir Crit Care Med (2007) 1.37

Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: virus persists and spreads systemically at late time points. Hum Gene Ther (2003) 1.35

Obliterative bronchiolitis. N Engl J Med (2014) 1.31

microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer. J Thorac Oncol (2013) 1.31

Mycobacterium tuberculosis sigma factor E regulon modulates the host inflammatory response. J Infect Dis (2008) 1.30

Mycobacterial antigens exacerbate disease manifestations in Mycobacterium tuberculosis-infected mice. Infect Immun (2002) 1.29

Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis. BMC Cancer (2005) 1.28

Crucial role of interleukin-1beta and nitric oxide synthase in silica-induced inflammation and apoptosis in mice. Am J Respir Crit Care Med (2002) 1.27

Resection of non-small cell lung cancers reverses tumor-induced gene expression changes in the peripheral immune system. Clin Cancer Res (2011) 1.24

Effect of highly active antiretroviral therapy on viral burden in the lungs of HIV-infected subjects. J Infect Dis (2008) 1.22

Detection of lung cancer using weighted digital analysis of breath biomarkers. Clin Chim Acta (2008) 1.21

Distal airway function in symptomatic subjects with normal spirometry following World Trade Center dust exposure. Chest (2007) 1.18

Differential role for CD80 and CD86 in the regulation of the innate immune response in murine polymicrobial sepsis. PLoS One (2009) 1.17

Identification of annexin 1 as a novel autoantigen in acute exacerbation of idiopathic pulmonary fibrosis. J Immunol (2008) 1.15

4-aminobiphenyl is a major etiological agent of human bladder cancer: evidence from its DNA binding spectrum in human p53 gene. Carcinogenesis (2002) 1.12

Characteristics of a residential and working community with diverse exposure to World Trade Center dust, gas, and fumes. J Occup Environ Med (2009) 1.12

CT scan screening for lung cancer: risk factors for nodules and malignancy in a high-risk urban cohort. PLoS One (2012) 1.12

Mycobacterium tuberculosis-induced CXCR4 and chemokine expression leads to preferential X4 HIV-1 replication in human macrophages. J Immunol (2004) 1.11

Mechanisms of polymorphonuclear neutrophil-mediated induction of HIV-1 replication in macrophages during pulmonary tuberculosis. J Infect Dis (2007) 1.08

Hedgehog signaling in neonatal and adult lung. Am J Respir Cell Mol Biol (2013) 1.06

Interleukin-10 induces inhibitory C/EBPbeta through STAT-3 and represses HIV-1 transcription in macrophages. Am J Respir Cell Mol Biol (2005) 1.06

HIV-associated lung infections and complications in the era of combination antiretroviral therapy. Proc Am Thorac Soc (2011) 1.05

Late expression of p53 from a replicating adenovirus improves tumor cell killing and is more tumor cell specific than expression of the adenoviral death protein. Hum Gene Ther (2002) 1.05

Mycobacterium tuberculosis malate synthase- and MPT51-based serodiagnostic assay as an adjunct to rapid identification of pulmonary tuberculosis. Clin Vaccine Immunol (2006) 1.05

Glucocorticoids inhibit lung cancer cell growth through both the extracellular signal-related kinase pathway and cell cycle regulators. Am J Respir Cell Mol Biol (2002) 1.04

A soluble factor(s) secreted from CD8(+) T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activation. J Virol (2002) 1.03

Performance of mitochondrial DNA mutations detecting early stage cancer. BMC Cancer (2008) 1.02

Preneoplastic lesions of the lung. Respir Res (2002) 1.01

Multiple strand displacement amplification of mitochondrial DNA from clinical samples. BMC Med Genet (2008) 1.00

N-hydroxy-4-aminobiphenyl-DNA binding in human p53 gene: sequence preference and the effect of C5 cytosine methylation. Biochemistry (2002) 1.00

Aryl hydrocarbon receptor and lung cancer. Anticancer Res (2013) 0.99

Human matrix metalloproteinase-8 gene delivery increases the oncolytic activity of a replicating adenovirus. Mol Ther (2007) 0.99

Gene expression profiles of bronchoalveolar cells in pulmonary TB. Tuberculosis (Edinb) (2007) 0.98

Proteome-scale antibody responses and outcome of Mycobacterium tuberculosis infection in nonhuman primates and in tuberculosis patients. J Infect Dis (2012) 0.96

Leprosy as immune reconstitution inflammatory syndrome in HIV-positive persons. Emerg Infect Dis (2007) 0.96

Inhibition of response to alpha interferon by Mycobacterium tuberculosis. Infect Immun (2003) 0.96

HIV-1 and bacterial pneumonia in the era of antiretroviral therapy. Proc Am Thorac Soc (2011) 0.95

Lung microbiome for clinicians. New discoveries about bugs in healthy and diseased lungs. Ann Am Thorac Soc (2014) 0.95

Immunomodulation with recombinant interferon-gamma1b in pulmonary tuberculosis. PLoS One (2009) 0.95

Cardiovascular biomarkers predict susceptibility to lung injury in World Trade Center dust-exposed firefighters. Eur Respir J (2012) 0.93

HLA-A2-restricted CD8+-cytotoxic-T-cell responses to novel epitopes in Mycobacterium tuberculosis superoxide dismutase, alanine dehydrogenase, and glutamine synthetase. Infect Immun (2004) 0.93

Aerosolized gamma interferon (IFN-gamma) induces expression of the genes encoding the IFN-gamma-inducible 10-kilodalton protein but not inducible nitric oxide synthase in the lung during tuberculosis. Infect Immun (2004) 0.93

Variant Ciz1 is a circulating biomarker for early-stage lung cancer. Proc Natl Acad Sci U S A (2012) 0.93

Health benefits from large-scale ozone reduction in the United States. Environ Health Perspect (2012) 0.92

Comparison of WTC dust size on macrophage inflammatory cytokine release in vivo and in vitro. PLoS One (2012) 0.90

Validation of a multiprotein plasma classifier to identify benign lung nodules. J Thorac Oncol (2015) 0.90

Clinical presentation of pulmonary mycetoma in HIV-infected patients. Chest (2002) 0.90

Surfactant protein A modulates the inflammatory response in macrophages during tuberculosis. Infect Immun (2004) 0.90

Neutrophils activate alveolar macrophages by producing caspase-6-mediated cleavage of IL-1 receptor-associated kinase-M. J Immunol (2010) 0.89

An official American Thoracic Society workshop report: Climate change and human health. Proc Am Thorac Soc (2012) 0.89

Gender and lung cancer. Clin Lung Cancer (2004) 0.88

Lung-specific expression of dominant-negative mutant p53 in transgenic mice increases spontaneous and benzo(a)pyrene-induced lung cancer. Am J Respir Cell Mol Biol (2002) 0.88

Protein kinase I of Mycobacterium tuberculosis: cellular localization and expression during infection of macrophage-like cells. Tuberculosis (Edinb) (2005) 0.87

Chromium(VI) exposure enhances polycyclic aromatic hydrocarbon-DNA binding at the p53 gene in human lung cells. Carcinogenesis (2003) 0.87

Bystander inhibition of dendritic cell differentiation by Mycobacterium tuberculosis-induced IL-10. Immunol Cell Biol (2010) 0.86

Small particles with big effects. Am J Respir Crit Care Med (2006) 0.86

Host defense responses to infection by Mycobacterium tuberculosis. Induction of IRF-1 and a serine protease inhibitor. J Biol Chem (2002) 0.85

Identification of novel hsp65 RFLPs for Mycobacterium leprae. J Drugs Dermatol (2007) 0.85

Arsenic enhances the activation of Stat1 by interferon gamma leading to synergistic expression of IRF-1. Oncogene (2003) 0.85